Powder: -20°C for 3 years | In solvent: -80°C for 1 year
P053 是一种有效的,非竞争性和选择性的神经酰胺合酶1 (CerS1) 抑制剂(IC50= 0.5 μM)。P053 作为肌肉线粒体脂肪酸氧化的内源性抑制剂和全身肥胖调节剂。
规格 | 价格/CNY | 货期 | 数量 | |
---|---|---|---|---|
500 μg | ¥ 1,760 | 35日内发货 | ||
1 mg | ¥ 3,360 | 35日内发货 | ||
5 mg | ¥ 9,730 | 35日内发货 | ||
10 mg | ¥ 17,600 | 35日内发货 |
产品描述 | P053 is a potent, non-competitive and selective ceramide synthase 1 (CerS1) inhibitor with an IC50 of 0.5 μM. P053 is an endogenous inhibitor of mitochondrial fatty acid oxidation in muscle and regulator of whole-body adiposity[1]. |
靶点活性 | CerS6 (human):11.4±0.17 μM , CerS2 (human):28.6±0.15 μM , CerS1 (mouse):0.46±0.08 μM , CerS4 (human):17.2±0.09 μM , CerS2 (mouse):18.5±0.12 μM , CerS5 (mouse):7.2±0.10 μM , CerS1 (human):0.54±0.06 μM |
体外活性 | P053 is the first isoform-specific ceramide synthase inhibitor with nanomolar potency. P053 inhibits different human (h) or murine (m) CerS isoforms hCerS1, mCerS1, hCerS2, mCerS2, hCerS4, mCerS5, and hCerS6 with IC 50 s of 0.54±0.06, 0.46±0.08, 28.6±0.15, 18.5±0.12, 17.2±0.09, 7.2±0.10, and 11.4±0.17 μM, respectively [1]. |
体内活性 | P053 (5 mg/kg; administered daily by oral gavage; 7 days, in male C57BL6/J mice ) lowers C18 ceramide levels in skeletal muscle (SkM) [1]. Daily P053 administration to mice fed a high-fat diet (HFD) increases fatty acid oxidation in skeletal muscle and impedes increases in muscle triglycerides and adiposity while not protect against HFD-induced insulin resistance [1]. Animal Model: Male C57BL6/J mice [1] Dosage: 5 mg/kg Administration: Oral gavage; daily Result: Reduced C18 ceramide levels in SkM by 31%, whereas 1 mg/kg/day had no effect. |
分子量 | 354.27 |
分子式 | C18H21Cl2NO2 |
CAS No. | 2748196-63-4 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
对于不同动物的给药剂量换算,您也可以参考 更多...
请在以下方框中输入您的动物实验信息后点击计算,可以得到母液配置方法和体内配方的制备方法: 比如您的给药剂量是10 mg/kg,每只动物体重20 g,给药体积100 μL,一共给药动物10 只,您使用的配方为5% DMSO+30% PEG300+5% Tween 80+60% ddH2O。那么您的工作液浓度为2 mg/mL。
母液配置方法:2 mg 药物溶于 50 μL DMSO (母液浓度为 40 mg/mL), 如您需要配置的浓度超过该产品的溶解度,请先与我们联系。
体内配方的制备方法:取 50 μL DMSO 主液,加入 300 μL PEG300, 混匀澄清,再加 50 μL Tween 80,混匀澄清,再加 600 μL ddH2O, 混匀澄清。
您可能有的问题的答案可以在抑制剂处理说明中找到,包括如何准备库存溶液,如何存储产品,以及基于细胞的分析和动物实验需要特别注意的问题。
P053 2748196-63-4 Others P 053 P-053 Inhibitor inhibitor inhibit